Login / Signup

Early Convalescent Plasma for High-Risk Outpatients with Covid-19.

Frederick K KorleyValerie Durkalski-MauldinSharon D YeattsKevin SchulmanRobertson D DavenportLarry J DumontNahed El KassarLydia D FosterJennifer M HahSiddartha JaiswalAlesia KaplanEzekiel LowellJohn F McDyerJames QuinnDarrell J TriulziCarol Van HuysenValerie L W StevensonKabir YadavChristopher W JonesBory KeaAaron BurnettJoshua C ReynoldsColin F GreinederNathan L HaasDavid G BeiserRobert SilbergleitWilliam BarsanClifton W Callawaynull null
Published in: The New England journal of medicine (2021)
The administration of Covid-19 convalescent plasma to high-risk outpatients within 1 week after the onset of symptoms of Covid-19 did not prevent disease progression. (SIREN-C3PO ClinicalTrials.gov number, NCT04355767.).
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus
  • clinical trial
  • sleep quality